Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience.
Saved in:
| Title: | Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. |
|---|---|
| Authors: | Brix, Gunnar1,2 gbrix@bfs.de, Henze, Marcus3, Knopp, Michael V.1, Lucht, Robert2, Doll, Josef1, Junkermann, Hans4, Hawighorst, Hans1, Haberkorn, Uwe1,3, Brix, G1 (AUTHOR), Henze, M (AUTHOR), Knopp, M V (AUTHOR), Lucht, R (AUTHOR), Doll, J (AUTHOR), Junkermann, H (AUTHOR), Hawighorst, H (AUTHOR), Haberkorn, U (AUTHOR) |
| Source: | European Radiology. Oct2001, Vol. 11 Issue 10, p2058-2070. 13p. |
| Subjects: | Medical imaging systems, Pharmacokinetics, Positron emission tomography, Cancer invasiveness, Diagnostic imaging, Medical radiography |
| Abstract: | It was the aim of this methodology-oriented clinical pilot study to compare the potential of dynamic MRI and 2-[18F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) for the detection and characterization of breast cancer. Fourteen women with suspicious breast lesions were examined. The MRI data were acquired with a turbo fast low-angle shot sequence and analyzed using a pharmacokinetic model. Emission data were detected in the sensitive 3D modus, iteratively reconstructed, and superimposed onto corresponding transmission images. In the 14 patients, 13 breast masses with a suspicious contrast enhancement and FDG uptake were detected. For these lesions, no statistically significant correlation between evaluated MR and PET parameters was found. Of the 9 histologically confirmed carcinomas, 8 were correctly characterized with MRI and PET. Two inflammatory lesions were concordantly classified as cancer. Moreover, dynamic MRI yielded another false-positive finding. In 6 patients, PET detected occult lymph node and/or distant metastases. Although both functional imaging techniques provide independent tissue information, the results concerning the diagnosis of primary breast lesions were almost identical. An advantage of PET, however, is its ability to localize lymph node involvement and distant metastases as an integral part of the examination. [ABSTRACT FROM AUTHOR] |
| Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 15654546 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Brix%2C+Gunnar%22">Brix, Gunnar</searchLink><relatesTo>1,2</relatesTo><i> gbrix@bfs.de</i><br /><searchLink fieldCode="AR" term="%22Henze%2C+Marcus%22">Henze, Marcus</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Knopp%2C+Michael+V%2E%22">Knopp, Michael V.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lucht%2C+Robert%22">Lucht, Robert</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Doll%2C+Josef%22">Doll, Josef</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Junkermann%2C+Hans%22">Junkermann, Hans</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Hawighorst%2C+Hans%22">Hawighorst, Hans</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Haberkorn%2C+Uwe%22">Haberkorn, Uwe</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Brix%2C+G%22">Brix, G</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Henze%2C+M%22">Henze, M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Knopp%2C+M+V%22">Knopp, M V</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lucht%2C+R%22">Lucht, R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Doll%2C+J%22">Doll, J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Junkermann%2C+H%22">Junkermann, H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hawighorst%2C+H%22">Hawighorst, H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Haberkorn%2C+U%22">Haberkorn, U</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Radiology%22">European Radiology</searchLink>. Oct2001, Vol. 11 Issue 10, p2058-2070. 13p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Medical+imaging+systems%22">Medical imaging systems</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacokinetics%22">Pharmacokinetics</searchLink><br /><searchLink fieldCode="DE" term="%22Positron+emission+tomography%22">Positron emission tomography</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+invasiveness%22">Cancer invasiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Diagnostic+imaging%22">Diagnostic imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+radiography%22">Medical radiography</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: It was the aim of this methodology-oriented clinical pilot study to compare the potential of dynamic MRI and 2-[18F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) for the detection and characterization of breast cancer. Fourteen women with suspicious breast lesions were examined. The MRI data were acquired with a turbo fast low-angle shot sequence and analyzed using a pharmacokinetic model. Emission data were detected in the sensitive 3D modus, iteratively reconstructed, and superimposed onto corresponding transmission images. In the 14 patients, 13 breast masses with a suspicious contrast enhancement and FDG uptake were detected. For these lesions, no statistically significant correlation between evaluated MR and PET parameters was found. Of the 9 histologically confirmed carcinomas, 8 were correctly characterized with MRI and PET. Two inflammatory lesions were concordantly classified as cancer. Moreover, dynamic MRI yielded another false-positive finding. In 6 patients, PET detected occult lymph node and/or distant metastases. Although both functional imaging techniques provide independent tissue information, the results concerning the diagnosis of primary breast lesions were almost identical. An advantage of PET, however, is its ability to localize lymph node involvement and distant metastases as an integral part of the examination. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=15654546 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s003300100944 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 2058 Subjects: – SubjectFull: Medical imaging systems Type: general – SubjectFull: Pharmacokinetics Type: general – SubjectFull: Positron emission tomography Type: general – SubjectFull: Cancer invasiveness Type: general – SubjectFull: Diagnostic imaging Type: general – SubjectFull: Medical radiography Type: general Titles: – TitleFull: Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brix, Gunnar – PersonEntity: Name: NameFull: Henze, Marcus – PersonEntity: Name: NameFull: Knopp, Michael V. – PersonEntity: Name: NameFull: Lucht, Robert – PersonEntity: Name: NameFull: Doll, Josef – PersonEntity: Name: NameFull: Junkermann, Hans – PersonEntity: Name: NameFull: Hawighorst, Hans – PersonEntity: Name: NameFull: Haberkorn, Uwe – PersonEntity: Name: NameFull: Brix, G – PersonEntity: Name: NameFull: Henze, M – PersonEntity: Name: NameFull: Knopp, M V – PersonEntity: Name: NameFull: Lucht, R – PersonEntity: Name: NameFull: Doll, J – PersonEntity: Name: NameFull: Junkermann, H – PersonEntity: Name: NameFull: Hawighorst, H – PersonEntity: Name: NameFull: Haberkorn, U IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2001 Type: published Y: 2001 Identifiers: – Type: issn-print Value: 09387994 Numbering: – Type: volume Value: 11 – Type: issue Value: 10 Titles: – TitleFull: European Radiology Type: main |
| ResultId | 1 |